Clinical Evaluation of a New Single-Tube Multiplex Reverse Transcription PCR Assay for Simultaneous Detection of 11 Respiratory Viruses, Mycoplasma Pneumoniae and Chlamydia in Hospitalized Children with Acute Respiratory Infections

Meng-chuan Zhao,Gui-Xia Li,Dan Zhang,Hang-yu Zhou,Hao Wang,Shuo Yang,Le Wang,Zhi-shan Feng,Xue-jun Ma
DOI: https://doi.org/10.1016/j.diagmicrobio.2017.03.010
IF: 2.983
2017-01-01
Diagnostic Microbiology and Infectious Disease
Abstract:Respiratory Pathogen 13 Detection Kit (13× kit) is able to simultaneously detect 11 respiratory viruses, Mycoplasma pneumoniae (MP) and Chlamydia in a single reaction. Using 572 Nasopharyngeal aspirates collected from hospitalized children, the clinical performance of 13× kit for detecting 11 respiratory viruses was evaluated in comparison with a routinely used 2-tube multiplex reverse transcription PCR assay (2-tube assay) at provincial Centers for Disease Control and Prevention in China. The clinical performance of 13× kit for detecting MP and Chlamydia was evaluated by commercial real-time quantitative PCR (qPCR) kits or sequencing. For tested viruses, the assay concordance was 95.98% and the kappa coefficient was 0.89. All the MP and Chlamydia positive samples detected by 13× kit were confirmed as true positives. The utilization of the 13× kit in clinical settings will be helpful for doctors to assess clinical outcome according to virus type or multiple infections, and to limit the use of antibiotics.
What problem does this paper attempt to address?